Not all patients with CLL call for therapy. In spite of all the latest advancements, the iwCLL nevertheless suggests watchful observation for people with asymptomatic condition.86 This suggestion is based on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Slot activity https://mahendrak801dba2.bloggazzo.com/profile